Modern treatment of chronic rhinosinusitis is moving beyond a one-size-fits-all approach toward identifying the underlying inflammatory drivers of disease and selecting treatment accordingly.

In this episode you’ll discover treatment options, from foundational therapies like saline irrigation and intranasal corticosteroids, to modern biologics that target specific inflammatory pathways, such as dupilumab, mepolizumab, omalizumab, and tezepelumab.

You’ll Also Discover:

• How your phenotype and endotype can help guide treatment decisions.
• How treatment sequencing (such as biologics first vs. surgery first) can be personalized for better outcomes
• How aspirin desensitization may reduce the need for systemic corticosteroids and help prevent nasal polyp recurrence in appropriately selected patients
• Endoscopic sinus surgery - what it can and can't do on its own
• How you can get personalized allergy and immune care